BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11243306)

  • 1. Autoantibodies to oxidized low-density lipoprotein in coronary artery disease.
    Sherer Y; Tenenbaum A; Blank M; Shemesh J; Harats D; Fisman EZ; Praprotnik S; Motro M; Shoenfeld Y
    Am J Hypertens; 2001 Feb; 14(2):149-54. PubMed ID: 11243306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control.
    Brandão SA; Izar MC; Fischer SM; Santos AO; Monteiro CM; Póvoa RM; Helfenstein T; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Fonseca FA
    Am J Hypertens; 2010 Feb; 23(2):208-14. PubMed ID: 19910928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
    Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):204-9. PubMed ID: 10634819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease].
    Maggi E; Perani G; Falaschi F; Frattoni A; Martignoni A; Finardi G; Stefano PL; Simeone F; Paolini G; DeVecchi E
    Presse Med; 1994 Jul 2-9; 23(25):1158-62. PubMed ID: 7971845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity modulates the immune response to oxidized LDL in hypertensive patients.
    Fonseca HA; Fonseca FA; Monteiro AM; Bianco HT; Boschcov P; Brandão SA; Juliano L; Gidlund M; Izar MC
    Cell Biochem Biophys; 2013; 67(3):1451-60. PubMed ID: 23559274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.
    Leinonen JS; Rantalaiho V; Laippala P; Wirta O; Pasternack A; Alho H; Jaakkola O; Ylä-Herttuala S; Koivula T; Lehtimäki T
    Free Radic Res; 1998 Aug; 29(2):137-41. PubMed ID: 9790515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating oxidized low-density lipoprotein is increased in hypertension.
    Frostegård J; Wu R; Lemne C; Thulin T; Witztum JL; de Faire U
    Clin Sci (Lond); 2003 Nov; 105(5):615-20. PubMed ID: 12837127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against oxLDL and acute coronary syndrome.
    Medeiros AM; von Mühlen CA; Gidlund MA; Bodanese R; Gottlieb MG; Bodanese LC
    Arq Bras Cardiol; 2010 Jul; 95(1):47-54. PubMed ID: 20563523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension.
    Wu R; de Faire U; Lemne C; Witztum JL; Frostegård J
    Hypertension; 1999 Jan; 33(1):53-9. PubMed ID: 9931081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.
    van Bommel EF; van Tits LJ; van den Berg EA; Prins J; Stalenhoef AF
    Rheumatol Int; 2011 Feb; 31(2):201-8. PubMed ID: 20012624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males.
    Barud W; Palusiński R; Bełtowski J; Wójcicka G
    Atherosclerosis; 2002 Oct; 164(2):283-8. PubMed ID: 12204799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension.
    Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Motro M; Shoenfeld Y
    Cardiology; 2002; 97(1):2-5. PubMed ID: 11893822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
    Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
    Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
    Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease.
    Rouhl RP; van Oostenbrugge RJ; Theunissen RO; Knottnerus IL; Staals J; Henskens LH; Kroon AA; de Leeuw PW; Lodder J; Tervaert JW; Damoiseaux JG
    Stroke; 2010 Nov; 41(11):2687-9. PubMed ID: 20947847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
    Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
    Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced levels of anti-MDA LDL antibodies in patients with carbohydrate metabolism disorders.
    Garrido-Sánchez L; García-Pinilla JM; Jiménez-Navarro M; Fernández-Pastora J; Alonso-Briales JH; Hernández-Garcia JM; De-Teresa-Galván E; Tinahones FJ
    Clin Lab; 2011; 57(11-12):901-7. PubMed ID: 22239020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.
    Virella G; Virella I; Leman RB; Pryor MB; Lopes-Virella MF
    Int J Clin Lab Res; 1993; 23(2):95-101. PubMed ID: 8518420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.